Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The morning after
Reply New Message
Prev Message Back To Forum Threaded View Next Message

The morning after

posted on Mar 26, 2008 10:01PM

PTSC volitility could be driven by 3 factors:

- significant variations in Q EPS (likely)

- uncertainty of the financial impact of an aquisition, near & long term (likely)

- uncertainty of new litigation (less likely to significantly impact SP)

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply